Current issues in adjuvant chemotherapy for resected, stage IB non-small-cell lung cancer

Affiliations

Comment

Hossein Borghaei et al. Future Oncol. 2009 Feb.

. 2009 Feb;5(1):19-22.

doi: 10.2217/14796694.5.1.19.

¹ Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA. hossein.borghaei@fccc.edu

No abstract available

Comment on

Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
Strauss GM, Herndon JE 2nd, Maddaus MA, Johnstone DW, Johnson EA, Harpole DH, Gillenwater HH, Watson DM, Sugarbaker DJ, Schilsky RL, Vokes EE, Green MR. Strauss GM, et al. J Clin Oncol. 2008 Nov 1;26(31):5043-51. doi: 10.1200/JCO.2008.16.4855. Epub 2008 Sep 22. J Clin Oncol. 2008. PMID: 18809614 Free PMC article. Clinical Trial.